CAY10506 can be used in cancer research; it acts as a PPARγ ligand that induces cell death and ROS generation in a PPARγ-dependent manner in vitro, and exhibits radiosensitizing effects by enhancing γ-radiation-induced apoptosis and caspase-3-mediated poly(ADP-ribose) polymerase (PARP) cleavage.